AI Partnerships for Clinical Trials Built for
Real-Time Execution
Maxis AI builds AI partnerships for clinical trials that help sponsors, CROs, technology providers, and site networks deploy governed AI across regulated clinical operations. We strengthen participation in FDA's Real-Time Clinical Trials (RTCT) initiative — including the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program.
Advancing Continuous, Data-Driven Regulatory Oversight
The FDA's Real-Time Clinical Trials (RTCT) initiative — and its AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program — is moving clinical development from periodic snapshots to continuous, data-driven oversight. Sponsors need a partner that can operationalize this shift under regulatory-grade governance. This partnership model enables organizations to deploy governed AI without replacing existing clinical systems.
Near-Real-Time Data Visibility
Unified, continuous view of safety, efficacy, and operational signals across sponsors, CROs, sites, and vendor systems.
Continuous Signal Monitoring
Governed AI agents track safety and efficacy signals as trials run — surfacing issues in time to act, not in retrospect.
Regulatory-Grade Governance
21 CFR Part 11-ready controls, validation checkpoints, and audit trails aligned with FDA expectations for AI in early-phase trials.
Proactive Regulatory Engagement
Structured evidence, human-in-the-loop review, and traceable actions that support continuous dialogue with regulators.
AI Partnerships for Clinical Trials
Clinical trials already run across sponsors, CROs, sites, vendors, and multiple systems.
The challenge is not only visibility. The challenge is execution.
Risks are identified, signals appear, and workflows are documented. But action often depends on manual handoffs, delayed escalation, and unclear ownership.
Maxis AI helps partners close this execution gap with the governed AI Workforce platform, where agents reason over trial context, coordinate workflows, support approved actions, and keep human teams in control.
From Signal to Governed Action
What are AI Partnerships for Clinical Trials?
AI partnerships for clinical trials combine AI technology providers with sponsors, CROs, research sites, and clinical platforms to improve execution, governance, and operational coordination while keeping humans in control.
Who We Partner With
Maxis AI develops Clinical AI Partnerships that help organizations deploy governed AI across regulated workflows.
CROs and Clinical Service Providers
Extend AI-enabled delivery across clinical operations, data management, biometrics, statistical programming, medical writing, and risk oversight.
Clinical Technology Platforms
Connect existing systems of record with governed AI execution across trial workflows.
Consulting and Transformation Partners
Support sponsors with clinical AI strategy, operating model design, governance planning, and enterprise adoption.
Site and Research Networks
Improve coordination, escalation, follow-up, and operational response across distributed site workflows.
Data and Analytics Partners
Move beyond insight generation by connecting data signals to supervised action paths.
Sponsor Innovation Teams
Explore governed AI execution models for clinical operations, real-time oversight, and scalable trial delivery.
What Partners Can Build with Maxis AI
Maxis AI helps partners build repeatable execution models for high-friction clinical trial workflows.
AI-Enabled Clinical Service Delivery
Help clinical teams execute more work without scaling headcount linearly. Maxis AI supports workflow coordination, task follow-up, documentation support, issue tracking, and operational response across trial functions.
Workflow-Specific AI Agents
Deploy governed agents for study startup, enrollment, clinical data management, biometrics, medical writing, and risk oversight workflows.
Governed Action Pathways
Turn risks, triggers, and trial signals into structured action paths with defined ownership, escalation, review, and auditability.
Control Tower for Clinical Trials
Support cross-functional oversight where risks, tasks, owners, and actions stay connected across studies, systems, and teams.
How AI Partnerships for Clinical Trials Work
Partnerships are designed around practical workflows, governance requirements, and repeatable deployment models.
Align
Identify the workflow, customer need, operational gap, and governance requirement.
Configure
Define the AI agents, approved actions, escalation rules, review points, and human oversight model.
Deploy
Connect Maxis AI into the relevant systems, teams, data environments, and clinical workflows.
Scale
Expand validated execution patterns across studies, sponsors, functions, or therapeutic areas.
Built for Agentic AI Partnerships for Regulated Clinical Operations
Clinical AI partnerships require more than technical integration. They require governance, traceability, validation, and human accountability. Maxis AI is designed for regulated clinical trial environments where responsible AI deployment matters.
Ensure regulatory compliance with FDA Alignment, ICH E6(R3), GAMP 5, SOC2, HIPAA, GDPR, 21 CFR Part 11
Partner Opportunities
Maxis AI supports multiple partnership models across clinical delivery, technology, consulting, and innovation.
RTCT Sponsor Partnership
For sponsors preparing for the FDA's Real-Time Clinical Trials initiative and the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program.
Apply HereDelivery Partnerships
For CROs and clinical service providers building AI-enabled, RTCT-ready clinical delivery models.
Apply HereTechnology Alliance & Partnerships
For platforms connecting trial data, workflows, and systems into governed near-real-time execution.
Apply HereInnovation Partnerships
For advisory firms and sponsor innovation teams operationalizing continuous, data-driven regulatory oversight.
Apply HereExplore our AI Workforce Platform
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.